Scinovex
article Open AccessTop 1% cited

Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

European Urology · 2017 · Vol. 73(2) · pp. 178–211
Silke GillessenGerhardt AttardTomasz M. BeerHimisha BeltranAlberto BossiRobert G. BristowBrett S. CarverDaniel CastellanoByung Ha ChungNoel W. ClarkeGedske DaugaardIan D. DavisJohann S. de BonoRodolfo Borges dos ReisCharles G. DrakeRosalind A. EelesEleni EfstathiouChristopher P. EvansStefano FantiFelix Y. FengKarim FizaziMark FrydenbergMartin GleaveSusan HalabiAxel HeidenreichCelestia S. HiganoNicholas D. JamesPhilip W. KantoffPirkko‐Liisa Kellokumpu‐LehtinenRaja B. KhauliGero KramerChris LogothetisFernando Cotait MalufAlicia K. MorgansMichael J. MorrisNicolas MottetVedang MurthyWilliam OhPiet OstAnwar R. PadhaniChris ParkerColin C. PritchardMack RoachMark A. RubinCharles J. RyanFred SaadOliver SartorHoward I. ScherAvishay SellaNeal D. ShoreMatthew R. SmithHoward R. SouleCora N. SternbergHiroyoshi SuzukiChristopher J. SweeneyMatthew R. SydesIan F. TannockBertrand TombalR. ValdagniThomas WiegelAurelius Omlin

Abstract

The Advanced Prostate Cancer Consensus Conference provides a forum to discuss and debate current diagnostic and treatment options for patients with advanced prostate cancer. The conference, which has been held three times since 2015, aims to share the knowledge of world experts in prostate cancer management with health care providers worldwide. At the end of the conference, an expert panel discusses and votes on predefined consensus questions that target the most clinically relevant areas of advanced prostate cancer treatment. The results of the voting provide a practical guide to help clinicians discuss therapeutic options with patients as part of shared and multidisciplinary decision making.

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentCancer, Lipids, and MetabolismMedicineProstate cancerProstateCancerManagement of prostate cancerConsensus conferenceProstate diseaseOncologyGynecologyGeneral surgery

MeSH terms

HumansMaleNeoplasm StagingProstatic NeoplasmsPractice Guidelines as Topic

Funding

  • Prostate Cancer Foundation
  • Amgen
  • Bristol-Myers Squibb
  • AstraZeneca
  • Sanofi
  • Movember Foundation
  • European School of Oncology
  • Astellas Pharma
  • Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung
  • Swiss Cancer Research Foundation
  • Sanofi Genzyme
  • Medical Research Council
  • National Health and Medical Research Council
Citations
639
FWCI
71.97
field-weighted impact
References
387
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.